AVITA Medical Inc（RCEL）价格预测

$16.500

+0.431 (+2.61%)收盘时

价格预测

1-Day Price Prediction

+0.79%

1-Week Prediction

-2.16%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

RCEL 相似图表分析预测

Alphio's RCEL stock price prediction model matches the current AVITA Medical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.63 (+0.79%). The 1-week path is $16.14 (-2.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 AVITA Medical Inc 股票吗？

AVITA Medical Inc. (RCEL) appears to be a good buy right now due to its current price of $15.51, which is well below the analyst price target of $15, suggesting a potential upside. The stock has shown impressive performance with a year-to-date change of +346.97% and a 5-day change of +18.94%, indicating strong momentum. However, the main risk is the negative net income, which was -$7.66 million in Q2 2026, highlighting ongoing financial challenges that investors should consider.

RCEL 股价于 Wednesday 收于 $16.50，此前上涨 +2.61%

AVITA Medical Inc (RCEL) last closed at $16.5, gaining +2.61%. These facts feed the 1-day and 1-week RCEL price prediction above.

预测驱动因素

AVITA Medical Inc（RCEL）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Negative

Bearish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

相似图表形态

近期走势与 RCEL 最接近的股票，按相似度排序。

SCHW

95.18%

-1.27%

ETN

92.91%

-10.27%

91.93%

-4.98%

OSS

91.27%

-22.19%

CLMT

90.39%

-14.36%

RCEL 季节性分析

Historically the probability of a positive October return for RCEL is 30.30%. February offers the highest probability of a positive month at 67.24%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…